Yahoo Web Search

Sign In

Search results

  1. www.researchgate.net › profile › Hiroyuki-KameiHiroyuki KAMEI | Meijo University, Nagoya | Research profile

    Hiroyuki KAMEI | Cited by 2,201 | of Meijo University, Nagoya | Read 92 publications | Contact Hiroyuki KAMEI

  2. pubmed.ncbi.nlm.nih.gov › 22130869Effects of single therapeutic doses of promethazine ... - PubMed

    Abstract. Since most first-generation antihistamines have undesirable sedative effects on the central nervous systems (CNS), newer (second-generation) antihistamines have been developed to improve patients' quality of life.

    • Hiroyuki Kamei, Ami Isaji, Yukihiro Noda, Kazuhiro Ishikawa, Koji Senzaki, Kiyofumi Yamada, Kazumits...
    • 2012

  3. orcid.org › 0000/0003/3846-2334Hiroyuki Kamei (0000-0003-3846-2334) - ORCID

    1954-03-09 to present | Professor (Museum) Employment. Show more detail. Source : Hiroyuki Kamei. How many people are using ORCID?

  4. www.ncbi.nlm.nih.gov › pmc › articlesEffects of single therapeutic doses of promethazine, fexofenadine...

    Dec 1, 2011 · When single therapeutic doses of fexofenadine (60 mg), olopatadine (5 mg) and promethazine (25 mg) were given in a double-blind manner to 24 healthy volunteers, all antihistamines produced a significant reduction in the wheal and flare responses induced by histamine.

    • Hiroyuki Kamei, Ami Isaji, Yukihiro Noda, Kazuhiro Ishikawa, Koji Senzaki, Kiyofumi Yamada, Kazumits...
    • 10.1007/s00403-011-1192-2
    • 2012
    • Arch Dermatol Res. 2012; 304(4): 263-272.

  5. pubmed.ncbi.nlm.nih.gov › 14696020Comparative study of acute effects of single doses of ... -...

    Hiroyuki Kamei 1 , Yukihiro Noda , Kazuhiro Ishikawa , Koji Senzaki , Isao Muraoka , Yoshinori Hasegawa , Ian Hindmarch , Toshitaka Nabeshima. Affiliation. 1 Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. PMID: 14696020. DOI: 10.1002/hup.538. Abstract.

    • Hiroyuki Kamei, Yukihiro Noda, Kazuhiro Ishikawa, Koji Senzaki, Isao Muraoka, Yoshinori Hasegawa, Ia...
    • 2003

  6. pubmed.ncbi.nlm.nih.gov › 33902519Scale development and an educational program to reduce the ... -...

    Apr 26, 2021 · We developed an assessment scale that is specifically designed to assess the level of stigma that pharmacists may have toward schizophrenia, and then examined the effects of reducing stigma with an educational program that focuses on communication with patients diagnosed with schizophrenia (PDS) using the newly developed Stigma Scale towards Sch...

  7. onlinelibrary.wiley.com › doi › 10The effects of different periods of co‐administration of oral and...

    Nov 27, 2018 · Hiroyuki Kamei, Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku, Nagoya City, Aichi 468-8503, Japan. Email: hkamei@meijo-u.ac.jp